Biological Products, (No Diagnostic Substances)
| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| Jupiter Topco LLC | 4.70M | $17.0M | 7.95% | -- | 2026-06-30 |
| BlackRock, Inc. | 3.66M | $13.0M | 6.20% | +268.5K | 2026-06-30 |
| Millennium Management LLC | 3.10M | $11.0M | 5.25% | +270.0K | 2026-06-30 |
| Velan Capital Investment Management LP | 2.84M | $10.0M | 4.81% | +10.0K | 2026-06-30 |
| Vanguard Capital Management LLC | 2.30M | $8.0M | 3.89% | +181.1K | 2026-06-30 |
| Blackstone Inc. | 2.27M | $8.0M | 3.83% | -- | 2026-06-30 |
| Orbimed Advisors LLC | 2.22M | $8.0M | 3.76% | -- | 2026-06-30 |
| Sio Capital Management, LLC | 1.92M | $7.0M | 3.25% | -48.0K | 2026-06-30 |
| Acorn Capital Advisors, LLC | 1.75M | $6.0M | 2.97% | -- | 2026-06-30 |
| Integral Health Asset Management, LLC | 1.50M | $5.0M | 2.54% | -250.0K | 2026-06-30 |
